HomeServicesCompetition LawChina

Competition Law in China

A wholly foreign-owned enterprise enters the Chinese market, completes its first major acquisition, and launches a distribution network – only to receive a dawn-raid notice from the national competition authority eight months later. The investigation covers pricing conduct that the parent company considered standard commercial practice in Europe. The cost of that assumption, measured in fines, forced divestitures, and reputational damage, can far exceed the original deal value.

Competition law in China is administered primarily by the State Administration for Market Regulation (SAMR), which enforces prohibitions on monopoly agreements, abuse of market dominance, and concentrations that restrict competition. Foreign businesses operating in China must comply with these rules regardless of where the relevant conduct originates. Pre-merger notification to SAMR is mandatory once prescribed thresholds are met, and failure to notify before closing an acquisition is an independent violation subject to significant penalties.

This page explains the principal instruments of Chinese competition law, the procedures and timelines that apply to international businesses. The most common compliance failures by foreign entrants. Additionally, the cross-border strategic considerations that arise where Chinese rules interact with UAE and EU competition regimes.

The regulatory system: how competition law operates in China

China's competition law regime rests on three pillars established under the country's antitrust legislation: the prohibition of monopoly agreements, the prohibition of abuse of market dominance, and the control of concentrations of undertakings. The State Council (China's highest executive authority) provides policy direction, while SAMR holds centralised enforcement power following a 2018 institutional reorganisation that merged three previously separate competition bodies into a single authority.

Monopoly agreements include horizontal arrangements between competitors – the classic cartel – as well as vertical arrangements between suppliers and distributors. Horizontal agreements fixing prices, dividing markets, or limiting output are treated as per se illegal. Vertical agreements, such as resale price maintenance, are subject to effect-based analysis but have been aggressively pursued in practice. Practitioners in China note that the prohibition on vertical price-fixing is applied more strictly than in many other jurisdictions, and international companies frequently underestimate the compliance risk embedded in their standard distribution contracts.

Abuse of market dominance covers conduct such as predatory pricing, refusal to deal, discriminatory pricing, and tying arrangements. The definition of dominance is broad. A single undertaking with a large share of the relevant market may be presumed dominant, and that presumption places the burden on the company to demonstrate otherwise. For businesses operating a wholly foreign-owned enterprise (WFOE) in a concentrated sector, this presumption requires active attention before market conduct decisions are made.

SAMR also operates sector-specific investigation units and coordinates with sectoral regulators in telecommunications, finance, and healthcare. This means that a technology company, a pharmaceutical distributor. Alternatively. A financial services provider may face concurrent scrutiny from both SAMR and a sector regulator. a doubling of compliance exposure that is not always anticipated during market entry planning.

Key instruments: merger notification, investigations, and enforcement tools

The merger notification system is the entry point where most international businesses first encounter Chinese competition law. Mandatory pre-merger notification is required when the combined turnover of all parties to a concentration exceeds the thresholds prescribed under SAMR regulations, calculated on both a global and a China-specific basis. Once thresholds are met, the transaction cannot close until SAMR issues either an unconditional clearance or a conditional approval attaching behavioural or structural remedies.

SAMR operates three review phases. The initial phase runs for approximately 30 days from acceptance of a complete notification filing. If SAMR determines that further review is required, a second phase of up to 90 days follows. In cases of particular complexity – typically those involving significant market concentration or remedies negotiations – a third phase of a further 60 days may be initiated. In practice, the total review period for complex filings regularly extends to five or six months from the date of formal acceptance.

A critical point for cross-border transactions is that the clock does not start until SAMR formally accepts the notification as complete. Incomplete filings that are returned for supplementation can add weeks or months to the timeline. International deal teams that underestimate the depth of China's information requirements – which include detailed market share data, competitive analysis, customer lists, and distribution agreements – often experience significant deal timetable disruption.

For cartel investigations and abuse-of-dominance cases, SAMR has broad investigative powers including dawn raids, production orders, interviews of employees, and seizure of electronic records. On-site inspections can take place across multiple locations simultaneously and without prior notice. Companies that have not established internal compliance procedures. response protocols, legal privilege safeguards, and employee training – are particularly exposed during the hours immediately following a raid, when consequential decisions must be made under pressure.

China maintains a leniency programme for cartel participants. The first undertaking to report a cartel to SAMR and provide evidence of its existence may obtain full immunity from fines. Subsequent applicants may receive partial reductions. Timing is critical: the leniency benefit diminishes significantly as the queue of applicants lengthens, and the programme is available only before SAMR has opened a formal investigation into the specific conduct in question.

For tailored advice on managing an SAMR investigation or structuring a leniency application, contact us at info@ferrazwhitmore.com.

Enforcement by SAMR can result in fines calculated as a percentage of the infringing party's annual sales in China. As well as orders to cease the infringing conduct, disgorgement of illegal gains, and. in the most serious cases – public disclosure of findings. Private antitrust litigation before Chinese civil courts, including actions for damages, has grown substantially. Parties harmed by anticompetitive conduct may bring claims before courts in the jurisdiction where the defendant is registered or where the harm occurred, and settlement negotiations increasingly run in parallel with regulatory proceedings.

International arbitration before the China International Economic and Trade Arbitration Commission (CIETAC). China's principal commercial arbitration body. is available for contractual disputes arising from competition-related conduct. Though competition law violations themselves are a matter of regulatory enforcement rather than arbitration. The intersection between CIETAC proceedings and SAMR investigations is a nuanced area, particularly where distribution agreements or technology licensing contracts contain clauses that may be impugned as anticompetitive. Businesses with ongoing corporate disputes in China that have a competition dimension should consider both tracks simultaneously.

Practical insights: what foreign businesses consistently underestimate

The most common compliance failure by foreign companies entering China is the assumption that conduct permissible in their home jurisdiction carries no risk in China. Resale price maintenance provisions in distribution agreements – legally tolerated in several common law systems under a rule of reason – have been a consistent enforcement priority for SAMR. Companies that import standard-form distribution contracts from their European or US operations without China-specific legal review expose themselves to enforcement risk from the moment the first contract is signed.

A second significant pitfall concerns the interaction between competition law and intellectual property licensing. China's competition regime scrutinises the terms of technology licensing agreements, particularly those involving patent pools, cross-licensing between competitors, and restrictions on licensee behaviour. A licensing structure that was designed solely around IP protection without competition law analysis may contain provisions that SAMR would characterise as a monopoly agreement or an abuse of dominance by a rights holder.

The extra-territorial reach of Chinese competition law is also frequently underestimated. Concentrations taking place entirely outside China – between two non-Chinese parties – still require SAMR notification if the turnover thresholds are met. Enforcement action for failure to notify a foreign-to-foreign transaction has been taken in practice. Deal teams planning global M&A transactions that include any meaningful China revenue must build SAMR notification into the pre-closing checklist at the earliest planning stage.

Digital platforms and data-driven businesses face a further layer of complexity. SAMR has issued detailed rules on anticompetitive practices in the platform economy, covering conduct such as exclusive dealing obligations imposed on merchants, algorithm-based price discrimination, and the use of data advantages to foreclose entry. For a technology company or e-commerce operator establishing a WFOE to access the Chinese market, these platform-specific rules require specific analysis that goes beyond standard competition law compliance.

Practitioners in China also note a de facto expectation that companies under investigation demonstrate a credible, ongoing compliance programme. The existence of a well-documented internal compliance system does not provide a legal defence, but it is a factor that SAMR considers in the context of remedies and penalty mitigation. Businesses that invest in compliance infrastructure before an investigation begins are materially better positioned than those that attempt to establish it after a raid.

Cross-border and strategic considerations: China, UAE, and EU dimensions

International businesses operating in China frequently maintain parallel operations in the UAE or within the EU, and competition law compliance in each jurisdiction creates distinct obligations that interact in commercially significant ways.

Where a company holds a dominant position in the Chinese market and also operates across the Gulf Cooperation Council states, conduct in China. for example. A refusal to supply a distributor. may have downstream effects on UAE-based distributors that attract scrutiny under UAE competition legislation as well. The UAE competition authority has in recent years expanded its enforcement activity, and coordinated or parallel investigations by SAMR and a Gulf-region regulator are a realistic risk for multinational suppliers in concentrated sectors. A comparative assessment of both regimes – particularly where product markets overlap – is an essential component of a cross-regional compliance strategy. Our analysis of competition law in the UAE sets out the relevant framework in detail.

The EU dimension arises most acutely in two contexts. First, EU merger control and Chinese merger control operate in parallel for cross-border transactions above their respective thresholds. A single acquisition may require simultaneous filings in Beijing and Brussels, with divergent substantive standards and potentially conflicting remedies conditions. Managing the sequencing of those filings – and ensuring that commitments offered to one authority do not create compliance problems for the other – requires coordinated cross-border legal counsel.

Second, EU foreign subsidies regulation has introduced new procedural obligations for transactions involving entities that have received Chinese state support. This creates an additional filing layer for acquisitions by Chinese state-owned enterprises or heavily subsidised private companies into EU targets. The interplay between Chinese merger control, EU merger control, and EU foreign subsidies screening represents one of the more complex multi-jurisdictional procedural challenges currently facing deal teams.

From a strategic standpoint, the decision whether to apply for leniency in China while a related cartel investigation is active in the EU or the USA requires careful sequencing. Information disclosed to SAMR under the Chinese leniency programme does not automatically obtain protection from disclosure in EU proceedings. Additionally. The evidential consequences of a multi-jurisdictional leniency strategy must be assessed before any application is made in any jurisdiction.

For a tailored strategy on managing competition law obligations across China, the UAE, and EU jurisdictions, reach out to info@ferrazwhitmore.com.

Self-assessment checklist for competition law compliance in China

Competition law compliance in China is applicable and requires active management if any of the following conditions are present:

  • Your business holds or may hold a significant share of a defined product or geographic market in China, including through group-level aggregation.
  • Your distribution, licensing, or supply agreements contain pricing restrictions, exclusivity obligations, or territorial limitations directed at Chinese market participants.
  • Your business is party to a transaction – including a joint venture formation – that may meet SAMR's merger notification thresholds, whether or not the target is a Chinese company.
  • Your business has been contacted by SAMR for information, or has received or anticipates receiving an on-site inspection notice.
  • Your business participates in trade association activities in China that involve any exchange of commercially sensitive information with competitors.

Before initiating any competition-sensitive procedure in China, verify the following critical points:

  • Merger notification: have all relevant turnover figures been calculated on a group basis, and has the China-specific threshold analysis been completed before the transaction is signed?
  • Distribution agreements: have all existing contracts governing resale prices, territorial allocation, and customer restrictions been reviewed against current SAMR enforcement priorities?
  • Leniency: if internal investigation has identified potentially cartel-related conduct, has a privilege-protected assessment of the leniency application window been completed?
  • Internal compliance: does the business have a documented dawn-raid response protocol, and have relevant employees received training on their rights and obligations during an on-site inspection?
  • Cross-border exposure: has the business mapped its competition law obligations across each jurisdiction where it operates, including China, the UAE, and EU member states, to identify procedural conflicts or parallel filing requirements?

Our guide to company formation in China addresses the structural decisions that shape competition law exposure from the outset of market entry.

Frequently asked questions

How long does SAMR merger review typically take, and how should we plan our deal timeline?
SAMR's initial review phase is approximately 30 days from formal acceptance of a complete filing. A second phase of up to 90 days can follow, with a further 60-day third phase available in the most complex cases. In practice, significant transactions routinely take five to six months from acceptance. Deal teams should build the notification preparation period. which can take four to eight weeks before acceptance. into the overall timetable. Additionally. Should not sign binding closing conditions that are inconsistent with a six-month regulatory review.
Can a foreign company apply for leniency in China if the relevant cartel conduct occurred entirely outside China but affected the Chinese market?
Yes. Chinese competition legislation applies to monopoly agreements that eliminate or restrict competition in the domestic market, regardless of where the agreement was formed or performed. A foreign company that participated in an international cartel affecting product prices or supply volumes in China is within SAMR's jurisdiction. Engaging a lawyer in China with cross-border competition experience is essential before making any leniency application, because the evidence requirements. Confidentiality protections. Additionally, interaction with parallel EU or US proceedings differ materially from what applicants may expect from their home jurisdiction.
Is a joint venture formation in China subject to merger notification?
Full-function joint ventures – those that operate on a lasting basis as an autonomous economic entity – are treated as concentrations under Chinese competition legislation and are subject to SAMR notification if the turnover thresholds are met. This applies even where the JV is newly formed and has no existing revenue, provided the parent entities meet the thresholds. A common misconception is that a greenfield joint venture with no turnover of its own falls outside the notification obligation. That is not the position under current SAMR practice, and failure to notify can result in significant penalties independent of any substantive competition concern.

About Ferraz & Whitmore

Ferraz & Whitmore is an international law firm in Lisbon advising business clients across 46 jurisdictions, including China and the broader Asia-Pacific region. Our competition law practice supports international businesses with SAMR merger notifications, cartel defence, dominance assessments, distribution agreement compliance, and multi-jurisdictional filing coordination across China, the UAE, and the EU. As a law firm in China-related matters, we combine Portuguese civil law expertise with English common law tradition to deliver practical, cross-border competition advice to corporate clients, investors, and in-house legal teams. The firm's competition team has advised on filing strategies before SAMR, coordinated parallel submissions under EU merger control, and supported clients through dawn-raid responses and leniency applications in high-stakes investigations. Our Lisbon base provides direct access to EU regulatory expertise, while our Asia-Pacific practice group handles China-specific procedural requirements with local counsel support. To discuss your competition law situation in China, schedule a consultation at info@ferrazwhitmore.com.

James Kellner Legal Analyst, IP & AI Law

James Kellner leads our Anglo-Saxon and Asia-Pacific desks and our AI & Technology Law practice. He advises US, UK and Singaporean technology companies on the full IP and tech-regulatory stack — patent licensing, software contracts, GDPR, the EU AI Act, employment and immigration for tech talent. James qualified as a solicitor in England & Wales and as an attorney in California. He spent five years at a Silicon Valley boutique focusing on patent and AI policy before joining Ferraz & Whitmore.

Disclaimer: This publication is provided for informational purposes only and does not constitute legal advice. The information herein should not be relied upon as a substitute for professional legal counsel tailored to your specific circumstances. Ferraz & Whitmore assumes no liability for actions taken or not taken based on the contents of this material. For advice regarding your particular situation, please contact info@ferrazwhitmore.com.